The paperwork a cosmetics shipment cannot clear without

Most categories a wholesaler handles are compliance-light: a commodity code, a commercial invoice, a packing list, and whatever the destination asks for at the border. Cosmetics are not one of them. The exposure sits in paper rather than in the goods, and it has to exist before the shipment moves rather than after it arrives.

The failure mode is worth stating precisely, because it is not the one people expect. A non-compliant consignment usually clears customs without difficulty — the border is rarely where this goes wrong. It then sits in a warehouse, because a retailer will not take it, a distributor will not risk it, and a regulator can order it off the market at any point afterwards.

The Responsible Person is not the factory

Every cosmetic product placed on the Great Britain market must have a Responsible Person established in the United Kingdom. The European Union operates the same structure, with a Responsible Person established in the EU. The role can be held by the manufacturer, the importer, a distributor selling under its own brand, or a third party appointed in writing to do it.

What it cannot be is nobody, and it cannot be a company outside the market. For a UK importer buying from a factory in Asia, the default is that the importer becomes the Responsible Person, and that is a decision with weight: the RP holds the file, signs the notification, and is the person the authority contacts. Buyers regularly acquire this obligation without noticing they have done so.

The four things that must exist before the goods do

• A Product Information File — the dossier for the product, covering description, the safety report, the method of manufacture with a statement of good manufacturing practice, evidence for any claimed effect, and animal testing data where relevant. It has to be kept accessible for ten years from the date the last batch was placed on the market.
• A Cosmetic Product Safety Report — held inside the file, in two parts: the safety information, and the assessment itself. It has to be signed by an assessor qualified in pharmacy, toxicology, medicine or a comparable discipline. It is not a formality and it cannot be back-dated.
• A notification — in Great Britain through the Submit Cosmetic Product Notifications service, before the product is made available; in the European Union through the CPNP. The two are separate systems and neither satisfies the other.
• Compliant labelling — in the language of the market, carrying the Responsible Person's name and address, nominal content, durability or period-after-opening, precautions, batch code, the function where it is not obvious, and the full ingredient list in INCI nomenclature in descending order of weight.

Labelling is where markets diverge

The same formulation, entirely legal in one market, can be non-compliant in another purely on how it is declared: a permitted concentration that differs, an ingredient restricted in one jurisdiction and not in another, a warning phrase whose wording is prescribed rather than paraphrased.

Since Great Britain and the European Union began maintaining their ingredient annexes separately, the two lists have begun to diverge, and they will keep diverging. A product formulated and labelled for one of those markets can no longer be assumed to be ready for the other, and the assumption that it can is one of the more expensive habits still in circulation.

The claim can change what the product legally is

The other boundary worth watching sits in the marketing copy rather than the ingredient list. A cosmetic is defined by what it does: cleaning, perfuming, changing appearance, protecting, keeping in good condition. A product presented as treating, preventing or curing a condition is making a medicinal claim — and a medicinal claim moves it into an entirely different regime, one built on licensing rather than notification.

This is a live problem in the categories that sit near the line: anti-ageing and anti-blemish skincare, anti-dandruff and hair-loss products, whitening, and anything sold with the percentage of an active ingredient in its name. The formulation may be completely ordinary. The claim is what reclassifies it.

For a wholesaler the practical consequence is that copy supplied by the manufacturer is not automatically safe to reuse. Text written for a market with looser rules on claims arrives with the goods, gets translated, and becomes the seller's problem the moment it appears on a listing.

The failure is almost always sequencing

Very little of this is difficult in itself. What makes it expensive is when it is done. The common pattern: the buyer agrees the product, agrees the price, places the order, and treats documentation as an administrative task to be completed while the goods are in transit.

By then the batch is filled, the artwork is approved and the labels are printed. Correcting an ingredient declaration at that point means relabelling — in a bonded warehouse if you are fortunate, back at origin if you are not — or reworking the batch entirely. Both are paid for by the buyer, on the buyer's timeline, against a delivery date that has not moved.

What to settle before production starts

1. 01Name the destination market or markets in writing, before the formulation is fixed.
2. 02Agree who the Responsible Person will be, and put it in the contract rather than discovering it later by default.
3. 03Obtain the full ingredient breakdown with percentages, and have it screened against the annexes for every market on the list.
4. 04Commission the safety assessment early enough that its findings can still change the formulation rather than only the paperwork.
5. 05Approve label artwork against the regulation, not against the brand guidelines, and approve it before print rather than after.
6. 06Agree batch coding and traceability with the manufacturer, so that a withdrawal is a withdrawal of one batch and not of everything you hold.

Treat the documentation as part of the specification and verify it at origin. It costs a conversation before production, and it saves a consignment that cannot be sold, cannot be returned economically, and cannot be written off quietly.